György Kéri Selected Research

Protein Kinase Inhibitors

3/2011	Protein kinase inhibitor as a potential candidate for epilepsy treatment.
6/2009	Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.
1/2009	Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.
8/2005	Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

György Kéri Research Topics

Disease

35	Neoplasms (Cancer) 09/2019 - 07/2002
4	Carcinoma (Carcinomatosis) 09/2017 - 06/2009
4	Inflammation (Inflammations) 01/2015 - 05/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014 - 10/2004
4	Neoplasm Metastasis (Metastasis) 05/2010 - 07/2002
3	Neurogenic Inflammation 11/2020 - 08/2002
3	Hyperalgesia 11/2020 - 08/2002
3	Colorectal Neoplasms (Colorectal Cancer) 04/2015 - 08/2007
2	Tuberculosis (Tuberculoses) 01/2017 - 03/2008
2	Melanoma (Melanoma, Malignant) 01/2016 - 05/2010
2	Insulin Resistance 01/2016 - 01/2014
2	Obesity 01/2016 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2010 - 03/2008
1	Neuralgia (Stump Neuralgia) 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Pathologic Neovascularization 01/2015
1	Triple Negative Breast Neoplasms 01/2014
1	Insulinoma 01/2014
1	Coinfection 01/2013
1	Extensively Drug-Resistant Tuberculosis 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Fibrosis (Cirrhosis) 01/2012
1	Seizures (Absence Seizure) 03/2011
1	Epilepsy (Aura) 03/2011
1	Colonic Neoplasms (Colon Cancer) 01/2010
1	Leukemia 07/2009
1	Bronchial Hyperreactivity 01/2008

Drug/Important Bio-Agent (IBA)

15	Phosphotransferases (Kinase)IBA 09/2017 - 03/2004
12	Pharmaceutical PreparationsIBA 11/2020 - 07/2002
7	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2002
6	Protein Kinases (Protein Kinase)IBA 01/2015 - 03/2008
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2011 - 08/2002
5	ErbB Receptors (EGF Receptor)IBA 04/2014 - 03/2005
4	Gefitinib (Iressa)FDA Link 08/2012 - 10/2004
4	Protein Kinase InhibitorsIBA 03/2011 - 08/2005
4	TT2-32IBA 01/2008 - 08/2002
3	Serine (L-Serine)FDA Link 01/2016 - 08/2005
3	multidrug resistance-associated protein 1IBA 04/2015 - 07/2002
3	tyrosine receptor (receptor, tyrosine)IBA 01/2014 - 08/2005
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 03/2005
3	Peptides (Polypeptides)IBA 07/2011 - 03/2003
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2010 - 10/2004
3	Tyrosine Kinase InhibitorsIBA 05/2010 - 07/2002
3	EnzymesIBA 03/2008 - 11/2005
2	PyrazinesIBA 01/2016 - 11/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 04/2015 - 08/2007
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2015 - 08/2007
2	fluorexon (calcein)IBA 04/2015 - 08/2007
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2015 - 01/2015
2	Axl Receptor Tyrosine KinaseIBA 04/2014 - 01/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 11/2013
2	Formaldehyde (Formol)FDA Link 09/2009 - 09/2004
2	Capsaicin (Zostrix)FDA Link 01/2008 - 05/2004
2	Tyrosine (L-Tyrosine)FDA Link 08/2005 - 03/2004
2	Analgesics (Analgesic Drugs)IBA 09/2004 - 05/2004
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	pyridineIBA 01/2016
1	Insulin Receptor Substrate ProteinsIBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2015
1	pyrazolanthroneIBA 05/2014
1	Estrogen ReceptorsIBA 05/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	PalmitatesIBA 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 11/2013
1	neratinibIBA 08/2012
1	EKB 569IBA 08/2012
1	vandetanib (ZD6474)IBA 08/2012
1	Sunitinib (Sutent)FDA Link 01/2012
1	SolutionsIBA 07/2011
1	Epidermal Growth Factor (EGF)IBA 06/2010
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 05/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2010
1	human ERBB2 proteinIBA 01/2010
1	Trastuzumab (Herceptin)FDA Link 01/2010
1	Cetuximab (Erbitux)FDA Link 01/2010
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	ParaffinIBA 09/2009
1	LigandsIBA 07/2009
1	Small Interfering RNA (siRNA)IBA 03/2008
1	ElementsIBA 03/2008
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2008
1	somatostatin receptor subtype-4IBA 01/2008
1	PeptidomimeticsIBA 01/2008
1	OvalbuminIBA 01/2008
1	2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA 01/2008
1	LipopolysaccharidesIBA 01/2008

Therapy/Procedure

19	Therapeutics 09/2019 - 09/2002
3	Drug Therapy (Chemotherapy) 04/2015 - 11/2005
1	Oral Administration 11/2020
1	Ligation 11/2020
1	Radiotherapy 01/2010